These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32281411)

  • 21. Regenerative medicine in kidney disease: where we stand and where to go.
    Borges FT; Schor N
    Pediatr Nephrol; 2018 Sep; 33(9):1457-1465. PubMed ID: 28735502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of kidney organoids derived from human pluripotent stem cells.
    Kim YK; Nam SA; Yang CW
    Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell and regenerative science applications in the development of bioengineering of renal tissue.
    Perin L; Giuliani S; Sedrakyan S; DA Sacco S; De Filippo RE
    Pediatr Res; 2008 May; 63(5):467-71. PubMed ID: 18427289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
    Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
    Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Utility of Human Kidney Organoids in Modeling Kidney Disease.
    Przepiorski A; Crunk AE; Espiritu EB; Hukriede NA; Davidson AJ
    Semin Nephrol; 2020 Mar; 40(2):188-198. PubMed ID: 32303281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative stem cell therapy.
    Coelho MB; Cabral JM; Karp JM
    Annu Rev Biomed Eng; 2012; 14():325-49. PubMed ID: 22809140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regenerative cellular therapies for neurologic diseases.
    Levy M; Boulis N; Rao M; Svendsen CN
    Brain Res; 2016 May; 1638(Pt A):88-96. PubMed ID: 26239912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparing regenerative therapies for clinical application: proposals for responsible translation.
    Shapiro SA; Smith CG; Arthurs JR; Master Z
    Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioengineering strategies to accelerate stem cell therapeutics.
    Madl CM; Heilshorn SC; Blau HM
    Nature; 2018 May; 557(7705):335-342. PubMed ID: 29769665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-based therapies for the preterm infant.
    Zhu D; Wallace EM; Lim R
    Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating stem cell therapies: the role of companion animals in regenerative medicine.
    Volk SW; Theoret C
    Wound Repair Regen; 2013; 21(3):382-94. PubMed ID: 23627495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regenerative treatments for kidney diseases: The closest and fastest strategies to solving related medical and economic problems.
    Osafune K
    Artif Organs; 2021 May; 45(5):447-453. PubMed ID: 33590913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of Muse Cell Therapy for Kidney Diseases.
    Uchida N; Kumagai N; Kondo Y
    Adv Exp Med Biol; 2018; 1103():199-218. PubMed ID: 30484231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine.
    Wang YC; Lin V; Loring JF; Peterson SE
    Expert Opin Biol Ther; 2015 May; 15(5):679-87. PubMed ID: 25736263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regenerative medicine for spinal cord injury: focus on stem cells and biomaterials.
    Papa S; Pizzetti F; Perale G; Veglianese P; Rossi F
    Expert Opin Biol Ther; 2020 Oct; 20(10):1203-1213. PubMed ID: 32421405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell therapy for the treatment of Peyronie's disease.
    Dellis A; Papatsoris A
    Expert Opin Biol Ther; 2017 Apr; 17(4):407-413. PubMed ID: 28274142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regenerative medicine: future impact on clinical therapies and society.
    Kargul J; Laurent GJ; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
    [No Abstract]   [Full Text] [Related]  

  • 38. Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.
    Garreta E; González F; Montserrat N
    Nephron; 2018; 138(1):48-59. PubMed ID: 28988229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials.
    Mizuno H
    Curr Opin Mol Ther; 2010 Aug; 12(4):442-9. PubMed ID: 20677095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Strategies for Niche-Dependent Cell Conversion to Assist Stem Cell Therapy.
    Del Sol A; Okawa S; Ravichandran S
    Trends Biotechnol; 2019 Jul; 37(7):687-696. PubMed ID: 30782480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.